No black box warning on record for Famotidine

As of the latest FDA labeling reviewed, Famotidine (FAMOTIDINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Famotidine medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Central Nervous System (CNS) Adverse Reactions: Elderly patients and patients with renal impairment at increased risk; reduce the dosage. ( 2.2 , 5.1 , 8.5 , 8.6 ) • GI Malignancy: Absence of GI symptoms does not preclude the presence of gastric malignancy; evaluate prior to initiating therapy. ( 5.2 ) 5.1 Central Nervous System Adverse Reactions Central nervous system

No black box warning on record for Famotidine

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Central Nervous System (CNS) Adverse Reactions: Elderly patients and patients with renal impairment at increased risk; reduce the dosage. ( 2.2 , 5.1 , 8.5 , 8.6 ) • GI Malignancy: Absence of GI symptoms does not preclude the presence of gastric malignancy; evaluate prior to initiating therapy. ( 5.2 ) 5.1 Central Nervous System Adverse Reactions Central nervous system

Famotidine Black Box Warning

No black box warning on record for Famotidine

Other warnings & precautions

Famotidine Black Box Warning

No black box warning on record for Famotidine

Other warnings & precautions